High level serum procalcitonin associated gouty arthritis susceptibility: From a Southern Chinese Han population

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Liu, Wen ^a   Sigdel, Keshav Raj ^a   Wang, Ying ^a   Su, Qun ^a   Huang, Yan ^a   Zhang, Yan Lin ^a   Chen, Jie ^b   Duan, Lihua ^a   Shi, Guixiu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; PROCALCITONIN; URIC ACID; BIOLOGICAL MARKER; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; PROTEIN PRECURSOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GOUT; HAN CHINESE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; AGED; ARTHRITIS, GOUTY; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; ETHNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

ADULT; AGED; ARTHRITIS, GOUTY; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; CREATININE; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; URIC ACID;

EID: 84941347394     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132855     Document Type: Article

References (39)

1. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiological research/Academia Scientiarum Bohemoslovaca. 2000; 49 Suppl 1:S57-S61. PMID: 10984072.
2. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis. The Lancet Infectious diseases. 2013; 13(5):426-35. doi:10.1016/S1473-3099(12)70323-7 PMID: 23375419.
3. Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: A review. Pathology. 2007; 39(4):383-90. PMID: 17676478.
4. Richette P, Bardin T. Gout. Lancet. 2010; 375(9711):318-28doi:10.1016/S0140-6736(09)60883-7 PMID: 19692116.
5. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and rheumatism. 2008; 58(1):26-35. doi:10.1002/art.23176PMID: 18163497.
6. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis and rheumatism. 2011; 63 (10):3136-41. doi:10.1002/art.30520 PMID: 21800283.
7. Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R, et al. Rheumatic diseases in China. Arthritis Research and Therapy. 2008; 10(1):R17. doi:10.1186/ar2368 PMID: 18237382.
8. Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis care & research. 2012; 64(10):1447-61.
9. Wang C, Zhong D, Liao Q, Kong L, Liu A, Xiao H. Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis. Experimental and therapeutic medicine. 2014; 8(4):1075-80. PMID: 25187799.
10. Saeed K, Ahmad N, Dryden M. The value of procalcitonin measurement in localized skin and skin structure infection, diabetic foot infections, septic arthritis and osteomyelitis. Expert review of molecular diagnostics. 2014; 14(1):47-54. doi:10.1586/14737159.2014.864238 PMID: 24308337.
11. Talebi-Taher M, Shirani F, Nikanjam N, Shekarabi M. Septic versus inflammatory arthritis: discriminating the ability of serum inflammatory markers. Rheumatology international. 2013; 33(2):319-24. doi:10.1007/s00296-012-2363-y PMID: 22447329.
12. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America. 2004; 39(2):206-17.
13. Dalbeth N, Zhong CS, Grainger R, Khanna D, Khanna PP, Singh JA, et al. Outcome measures in acute gout: A systematic literature review. The Journal of rheumatology. 2014; 41(3):558-68. doi:10.3899/jrheum.131244PMID: 24334652.
14. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis research & therapy. 2005; 7(4):R796-R806.
15. Heegaard C, Dreyer L, Egsmose C, Madsen OR. Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints. Clinical rheumatology. 2013; 32(10):1493-500. doi:10.1007/s10067-013-2300-9 PMID: 23754243.
16. Fernandez-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, et al. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Annals of the rheumatic diseases. 2014; 73(7):1350-5. doi:10.1136/annrheumdis-2012-202976 PMID: 23709245.
17. Shaikh MM, Hermans LE, van-Laar JM. Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections. Rheumatology (Oxford, England). 2014.
18. Hugle T, Schuetz P, Mueller B, Laifer G, Tyndall A, Regenass S, et al. Serum procalcitonin for discrimination between septic and non-septic arthritis. Clinical and experimental rheumatology. 2008; 26 (3):453-6. PMID: 18578968.
19. Okada Y, Minakami H, Tomomasa T, Kato M, Inoue Y, Kozawa K, et al. Serum procalcitonin concentration in patients with Kawasaki disease. The Journal of infection. 2004; 48(2):199-205. PMID: 14720497.
20. Chen DY, Chen YM, Ho WL, Chen HH, Shen GH, Lan JL. Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adultonset Still's disease. Annals of the rheumatic diseases. 2009; 68(6):1074-5. doi:10.1136/ard.2008.098335 PMID: 19435724.
21. Shah K, Spear J, Nathanson LA, McCauley J, Edlow JA. Does the presence of crystal arthritis rule out septic arthritis? The Journal of emergency medicine. 2007; 32(1):23-6. PMID: 17239729.
22. NP V, KT J, JC M. Concomitant septic arthritis and tophaceous gout of the knee managed with intermittent closed joint irrigation combined with negative pressure therapy: A case study and literature review. The open orthopaedics journal. 2014; 8:482-7. doi:10.2174/1874325001408010482 PMID: 25621084.
23. Weng CT, Liu MF, Lin LH, Weng MY, Lee NY, Wu AB, et al. Rare coexistence of gouty and septic arthritis: A report of 14 cases. Clinical and experimental rheumatology. 2009; 27(6):902-6. PMID: 20149303.
24. Becker K, Nylen E, White J, Muller B, Snider R Jr. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors. The Journal of Clinical Endocrinology & Metabolism. 2004; 89(4):1512-25.
25. Kettelhack C, Hohenberger P, Schulze G, Kilpert B, Schlag PM. Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan. Critical care medicine. 2000; 28(4):1040-6. PMID: 10809279.
26. Liote F, Ea HK. Gout: update on some pathogenic and clinical aspects. Rheumatic diseases clinics of North America. 2006; 32(2):295-311, vi. PMID: 16716881.
27. Petrilli V, Martinon F. The inflammasome, autoinflammatory diseases, and gout. Joint, bone, spine: Revue du rhumatisme. 2007; 74(6):571-6.
28. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440(7081):237-41. PMID: 16407889.
29. Ottaviani S, Molto A, Ea HK, Neveu S, Gill G, Brunier L, et al. Efficacy of anakinra in gouty arthritis: A retrospective study of 40 cases. Arthritis research & therapy. 2013; 15(5):R123.
30. Badulescu M, Macovei L, Rezus E. Acute gout attack with normal serum uric acid levels. Rev Med Chir Soc Med Nat Iasi. 2014; 118(4):942-5. PMID: 25581951.
31. Soderquist B, Jones I, Fredlund H, Vikerfors T. Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers. Scandinavian journal of infectious diseases. 1998; 30(6):591-6. Epub 1999/05/04. PMID: 10225388.
32. Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Begue RJ, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Annals of the rheumatic diseases. 2003; 62(4):337-40. PMID: 12634233.
33. Martinot M, Sordet C, Soubrier M, Puechal X, Saraux A, Liote F, et al. Diagnostic value of serum and synovial procalcitonin in acute arthritis: A prospective study of 42 patients. Clinical and experimental rheumatology. 2005; 23(3):303-10. PMID: 15971417.
34. Limper M, van-de-Stadt L, Bos W, de-Kruif M, Spek A, Wolbink G, et al. The acute-phase response is not predictive for the development of arthritis in seropositive arthralgia-a prospective cohort study. The Journal of rheumatology. 2012; 39(10):1914-7. doi:10.3899/jrheum.120586 PMID: 22859350.
35. Sato H, Tanabe N, Murasawa A, Otaki Y, Sakai T, Sugaya T, et al. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis. The Journal of rheumatology. 2012; 39 (8):1517-23. doi:10.3899/jrheum.111601 PMID: 22753652.
36. Ozmen M, Oktay E, Tarhan EF, Aslan O, Oflazoglu U, Koseoglu MH. Serum procalcitonin levels in patients with ankylosing spondylitis. International journal of rheumatic diseases. 2014.
37. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis and rheumatism. 1997; 40(7):1250-6. PMID: 9214425.
38. Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. European journal of anaesthesiology. 2001; 18(2):79-87. PMID: 11270029.
39. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: Past, present and future. BMC medicine. 2011; 9:107. doi:10.1186/1741-7015-9-107 PMID: 21936959.